XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
Revenue $ 607,494 $ 764,063 $ 1,479,781 $ 1,560,157
Cost of revenue (exclusive of amortization shown separately below) (384,381) (564,815) (909,867) (1,128,578)
Gross profit 223,113 199,248 569,914 431,579
Other income:        
Government support income 133,640 153,204 259,768 263,075
Operating expenses        
Selling, general and administrative expenses (1,809,114) (1,705,044) (3,758,130) (4,162,104)
Development and regulatory approval expenses (506,944) (348,452) (1,455,696) (452,399)
Depreciation and amortization (305,177) (290,313) (605,599) (597,873)
Total operating expenses (2,621,235) (2,343,809) (5,819,425) (5,212,376)
Loss from operations (2,264,482) (1,991,357) (4,989,743) (4,517,722)
Other income (expense), net        
Interest expense (13,502) (32,468) (35,829) (69,916)
Realized foreign exchange loss (750) (555) (801) (555)
Fair value gain on revaluation of financial instrument 44,488 175,738
Interest income 21,937 3,509 74,777 3,648
Total other income, net 7,685 14,974 38,147 108,915
Net loss (2,256,797) (1,976,383) (4,951,596) (4,408,807)
Net loss attributable to non-controlling interest (7,327) (6,742) (16,493) (13,962)
Net loss attributable to Intelligent Bio Solutions Inc. (2,249,470) (1,969,641) (4,935,103) (4,394,845)
Other comprehensive income (loss), net of tax:        
Foreign currency translation gain (loss) (143,165) 75,133 73,190 57,117
Total other comprehensive income (loss) (143,165) 75,133 73,190 57,117
Comprehensive loss (2,399,962) (1,901,250) (4,878,406) (4,351,690)
Comprehensive loss attributable to non-controlling interest (7,327) (6,742) (16,493) (13,962)
Comprehensive loss attributable to Intelligent Bio Solutions Inc. $ (2,392,635) $ (1,894,508) $ (4,861,913) $ (4,337,728)
Net loss per share, basic $ (0.50) $ (2.07) $ (1.18) $ (7.68)
Net loss per share, diluted $ (0.50) $ (2.07) $ (1.18) $ (7.68)
Weighted average shares outstanding, basic 4,535,815 949,660 4,173,452 571,930
Weighted average shares outstanding, diluted 4,535,815 949,660 4,173,452 571,930